ISI Group Believes That Genzyme Corporation (GENZ) Could Jump to $80

Mark Schoenebaum of ISI Group said on CNBC's Fast Money that a rumor that Sanofi-Aventis SA (ADR) (NYSE: SNY) could buy Genzyme Corporation (NASDAQ: GENZ) makes a lot of sense.

He explained that Genzyme (GENZ) is still run by its founding CEO. He is 66 years old, and the company has some manufacturing problems. Mark Schoenebaum believes that this could be the CEO's chance for a graceful exit. He added that we could be months away from this acquisition, if it happens at all.

Mark Schoenebaum believes that the stock could move to $80, if the speculation proves to be right. If you think that the takeover will happen, it is still not too late to buy this stock, thinks Mr. Schoenebaum. On the other hand if it doesn't happen, we will see a 10% decline.

Genzyme (GENZ) added 0.19% today, and closed at $67.51.

Strong Buy Stocks That Have Tripled the Market. See them for free.